These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18490399)

  • 1. The financial impact of heparin-induced thrombocytopenia.
    Smythe MA; Koerber JM; Fitzgerald M; Mattson JC
    Chest; 2008 Sep; 134(3):568-573. PubMed ID: 18490399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
    Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
    Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Platelet Functional Assays on the Cost of Treating Suspected Heparin-Induced Thrombocytopenia.
    Sadik ZG; Jennings DL; Nemerovski CW; Kuriakose P; Kalus JS
    J Pharm Pract; 2015 Aug; 28(4):398-403. PubMed ID: 24532821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France.
    Elalamy I; Le Gal G; Nachit-Ouinekh F; Lafuma A; Emery C; Le-Fur C; Chapuis F
    Clin Appl Thromb Hemost; 2009; 15(4):428-34. PubMed ID: 18544593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heparin-induced thrombocytopenia task force model: implementing quality improvement and economic outcome initiatives.
    Frame JN
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S28-35. PubMed ID: 16105556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The direct medical costs associated with suspected heparin-induced thrombocytopenia.
    Nanwa N; Mittmann N; Knowles S; Bucci C; Selby R; Shear N; Walker SE; Geerts W
    Pharmacoeconomics; 2011 Jun; 29(6):511-20. PubMed ID: 21473656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
    Gettings EM; Brush KA; Van Cott EM; Hurford WE
    Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital.
    Smythe MA; Koerber JM; Mattson JC
    Chest; 2007 Jun; 131(6):1644-9. PubMed ID: 17400685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and cost.
    Smythe MA; Koerber JM; Mehta TP; Forsyth LL; Conger E; Corbets LR; Mattson JC
    Thromb Haemost; 2012 Nov; 108(5):992-8. PubMed ID: 22955669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current hospital costs and medicare reimbursement for endovascular abdominal aortic aneurysm repair.
    Bertges DJ; Zwolak RM; Deaton DH; Teigen C; Tapper S; Koslow AR; Makaroun MS
    J Vasc Surg; 2003 Feb; 37(2):272-9. PubMed ID: 12563195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia in cardiac surgery: Incidence, costs, and duration of stay.
    Aguayo E; Sanaiha Y; Seo YJ; Mardock A; Bailey K; Dobaria V; Benharash P
    Surgery; 2018 Dec; 164(6):1377-1381. PubMed ID: 30213436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study.
    Dhakal B; Kreuziger LB; Rein L; Kleman A; Fraser R; Aster RH; Hari P; Padmanabhan A
    Lancet Haematol; 2018 May; 5(5):e220-e231. PubMed ID: 29703336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups.
    Tong KB; Lau CJ; Murtagh K; Layton AJ; Seifeldin R
    Int J Infect Dis; 2009 Jan; 13(1):24-36. PubMed ID: 18621562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia type II in a surgical intensive care unit.
    Sakr Y; Haetscher F; Gonsalves MD; Hoffman M; Theis B; Barz D; Reinhart K; Kortgen A
    J Crit Care; 2012 Jun; 27(3):232-41. PubMed ID: 21855286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic assessment of thrombocytopenia: CATCH Registry.
    Eisenstein EL; Honeycutt EF; Anstrom KJ; Becker RC; Granger CB; Rao SV; Jolicoeur ME; Ohman EM;
    J Med Syst; 2010 Jun; 34(3):379-86. PubMed ID: 20503623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of case type, length of stay, institution type, and comorbidities on Medicare diagnosis-related group reimbursement for adult spinal deformity surgery.
    Nunley PD; Mundis GM; Fessler RG; Park P; Zavatsky JM; Uribe JS; Eastlack RK; Chou D; Wang MY; Anand N; Frank KA; Stone MB; Kanter AS; Shaffrey CI; Mummaneni PV;
    Neurosurg Focus; 2017 Dec; 43(6):E11. PubMed ID: 29191102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program.
    Ritchie BM; Sylvester KW; Reardon DP; Churchill WW; Berliner N; Connors JM
    J Thromb Thrombolysis; 2016 Nov; 42(4):616-22. PubMed ID: 27501998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.
    Sylvester KW; Fanikos J; Anger KE; Matta L; Southard RA; Beik N; Lemire SJ; Dorfman DM; Berliner N
    Pharmacotherapy; 2013 Nov; 33(11):1191-8. PubMed ID: 23813781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs of heparin-induced thrombocytopenia: a patient-based cost of illness analysis.
    Wilke T; Tesch S; Scholz A; Kohlmann T; Greinacher A
    J Thromb Haemost; 2009 May; 7(5):766-73. PubMed ID: 19220728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.